Clinical Trials Directory

Trials / Completed

CompletedNCT00081744

Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects

A Multicenter, Double-Blind, Randomized Comparison Study Of the Efficacy and Safety of Tigecycline to Imipenem/ Cilastatin to Treat Complicated Intra-Abdominal Infections in Hospitalized Subjects

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
850 (actual)
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer · Industry
Sex
All
Age
8 Years
Healthy volunteers
Not accepted

Summary

Purpose: To provide a mechanism for the emergency use of tigecycline in the appropriate clinical situations.

Conditions

Interventions

TypeNameDescription
DRUGTigecycline

Timeline

Start date
2002-11-01
Primary completion
2004-08-01
Completion
2004-08-01
First posted
2004-04-21
Last updated
2013-02-08

Source: ClinicalTrials.gov record NCT00081744. Inclusion in this directory is not an endorsement.